PROTOCOL ABS4986g TISSUE BIOPSY SUBSTUDY: A COLONIC BIOPSY SUBSTUDY IN ASSOCIATION WITH rhuMAb BETA7 STUDY ABS4986g TO ASSESS CHANGES IN IMMUNE CELL COMPOSITION IN THE GUT MUCOSA OF PATIENTS RECEIVING rhuMAb BETA7 [SUBSTUDY OF 700197675]

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 17 Jun 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Etrolizumab (Primary)
Indications Ulcerative colitis
Focus Pharmacodynamics
Sponsors Genentech

Most Recent Events

30 Mar 2016 Status changed from active, no longer recruiting to completed.
23 Apr 2013 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight